ADHD medication in short supply in Japan as demand soars
Since last fall, Concerta, a medication used for the treatment of attention-deficit/hyperactivity disorder (ADHD), has been in short…
Eli Lilly reaches deal to bring AI-developed drugs to global market
A drone view shows the Eli Lilly logo on the company’s office in San Diego, California, Nov. 21,…
FDA approves new ‘Wegovy HD’ with triple the dosage of the semaglutide medication
The US Food and Drug Administration announced on Thursday its approval of a new, higher-dose Wegovy (semaglutide) injection.…
Pharma penalties for doctors’ kickbacks just a cost of doing business
Pharmaceutical companies that were penalized for kickbacks paid only 2.2% of their U.S. revenue generated by selling drugs…
Pfizer Lyme disease vaccine fails trial, company to seek FDA approval
Thomas Fuller | Nurphoto | Getty Images Pfizer on Monday said it will seek regulatory approval for a…
Ozempic is getting generics as low as $15 — what it means for Americans
The weight-loss world is on the brink of a major shake-up. Pharmaceutical companies in India will get the…
New polygenic risk scores improve prediction of metabolic disease outcomes
Type 2 diabetes (T2D) and obesity are metabolic conditions with many causes, including overlapping and distinct genetic features.…
Ozempic Maker Sued After Woman Died From Stomach Paralysis
The maker of Ozempic, Novo Nordisk, has been hit with a lawsuit over allegations of wrongful death after…
GOP Sen. Johnson investigating FDA rare disease drug rejections
WASHINGTON — Sen. Ron Johnson (R-Wis.) said he is investigating the Food and Drug Administration’s rejections of rare disease…
Battle to get ‘female Viagra’ to market — and how ‘Grey’s Anatomy’ played a role
You’ve heard of the little blue pill. Now, a new documentary is turning the spotlight on the pink…
TrumpRx: High expectations, but limited impact a month after launch
WASHINGTON — President Trump heralded his signature drug discount platform, TrumpRx, as “one of the most transformative health…
Eli Lilly launches program to boost employer coverage of obesity drugs
Eli Lilly on Thursday launched a new program designed to help more employers cover obesity drugs in the…